NYLIM
DVAX

New York Life Investment Management’s Dynavax Technologies DVAX Stock Holding History

New York Life Investment Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-28,826
Closed -$358K – 995
2024
Q1 		$358K Buy
+28,826
New +$376K ﹤0.01% 1247

Other funds holding DVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

New York Life Investment Management's DVAX Position: Q2 2024 in Review

New York Life Investment Management sold out of Dynavax Technologies (DVAX) in Q2 2024, closing a stake of 28,826 shares — an estimated $358K sold.

New York Life Investment Management first reported a position in DVAX in Q1 2024 and held it in 1 quarter. The position peaked at $358K in Q1 2024. 238 funds tracked by Wall St. Rank hold DVAX as of Q2 2024.

  • New York Life Investment Management reported no remaining Dynavax Technologies position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 28,826 Dynavax Technologies shares in Q2 2024, an estimated $358K.
  • New York Life Investment Management first reported a position in Dynavax Technologies in Q1 2024 and held it in 1 quarter.
  • New York Life Investment Management's Dynavax Technologies position peaked at $358K in Q1 2024.
  • 238 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.